SofWave Medical
Company page · Medical devices

SofWave Medical

TASE : SOFWISIN : IL0011754392Headquarters: Yokneam IllitIFRS accounts · in $M

SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin firming and rejuvenation, tissue renewal, treatment of muscle, aging, and other physiological change in Israel, the United States, Europe, Southeast Asia, the Middle East, and internationally. Based in Yokneam Illit.

Price₪35.96−1.9% · session of 12/11/2026
Market cap₪1.3bnprice × number of shares
Next resultsno later than 31/03/2027Annual report
1-year price+30.8% over the period
Analysis in brief · first nine months 2026

SofWave Medical: net income sharply up (+467.8%), sales sharply up (+41.1%), operating income sharply up (+228.5%).

  • Net income sharply up

    Net income: $8M, vs. $1M a year earlier, i.e. +467.8%.

    First nine months 2026
  • Sales sharply up

    Revenue: $83M, vs. $59M a year earlier, i.e. +41.1%.

    First nine months 2026
  • Operating income sharply up

    Operating income: $9M, vs. $3M a year earlier, i.e. +228.5%.

    First nine months 2026
  • Cash flow sharply up

    Operating cash flow: $6M, vs. $5M a year earlier, i.e. +18.0%.

    First nine months 2026
Built automatically from the published figures.
Valuation

What the market pays, vs. the sector

P/E34.2price / net income over 12 months
P/B9.6market cap / equity
Dividend yield0%dividends over the last 12 months / price
12-month range₪27.50 – ₪46.14monthly closes

This company's valuation multiples history is being built day by day from now on.

P/E calculated on net income (trailing 12 months: last fiscal year + 2026 year-to-date − same period a year earlier). Sector median: companies in the — group tracked here. Prices: Yahoo Finance; market cap cross-checked with the Tel Aviv Stock Exchange for Israeli stocks. These ratios describe a price, not a value: none of them says whether the share is expensive or cheap.

Insiders

Trades by executives and interested parties

17 filing(s) over 12 months · on shares: 2 increase(s) and 13 decrease(s) in holdings.

DateHolderSecurityDirectionQuantityPrice
11/11/2026Shimon Eckhouse
Director
SharesDown1,433,421₪36.33Maya ›
22/09/2026Scafuri Louis
Director
SharesUp369,009—Maya ›
11/08/2026Scafuri Louis
Director
SharesDown21,500₪1.12Maya ›
17/06/2026Assaf Korner
Executive
SharesDown2,138₪38.98Maya ›
16/06/2026Assaf Korner
Executive
SharesDown7,622₪39.85Maya ›
15/06/2026Assaf Korner
Executive
SharesDown42,701—Maya ›
01/06/2026Tali Malach
Executive
SharesDown30,000₪45.03Maya ›
29/05/2026Ruthie Amir
Executive
OptionsDown8,206₪45.00Maya ›
28/05/2026Panir Erez
Executive
SharesDown38,640₪43.78Maya ›
18/05/2026XT HI-TECH INVESTMENTS (1992) LTD
Interested party
SharesDown1,471,000₪41.00Maya ›
13/05/2026Ruthie Amir
Executive
OptionsDown55,000₪45.00Maya ›
04/05/2026Miguel Pardos
Executive
SharesUp35,000—Maya ›

Filings submitted on Maya (executives, directors, shareholders above 5%). An increase or decrease in holdings may come from a purchase or sale on the exchange, but also from a grant or exercise of options (price "—": grant with no price). Bonds excluded. For details, see the filing on Maya.

Follow earnings · WhatsApp group TA-125Details ▾
WhatsApp group · TA-125

Every report from a TA-125 company, analyzed the same day: key figures and year-on-year change, analysis in brief, share price reaction. One daily summary during earnings season.

Detailed figures and history
The figures

Financial summary

9 months 20269 months 2025FY 2025
Total assets664756
Current assets614251
Non-current assets555
Equity432833
of which minority interests000
Current liabilities221822
Non-current liabilities111
Revenue835988
Gross profit634466
Operating income937
Pre-tax income826
Net income815
Net income (attributable to shareholders)815
Dividends paid000
Operating cash flow6513

In millions of dollars. The "H1" columns cover the first six months of the year.

Ratios

Calculated from these figures

9 months 20269 months 2025FY 2025
Gross margin76.1%75.1%75.3%
Operating margin10.7%4.6%7.8%
Net margin9.5%2.4%6.3%
Current ratio (current assets / current liabilities)2,7 x2,4 x2,3 x
Equity / total assets64.6%59.7%58.7%

The 5-year history, charts and cross-check models are coming for companies listed only in Tel Aviv: each new filing on Maya is kept and enriches the page.

Company overview

SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin firming and rejuvenation, tissue renewal, treatment of muscle, aging, and other physiological change in Israel, the United States, Europe, Southeast Asia, the Middle East, and internationally. The company offers an ultrasound technology that induces coagulation and subsequent revitalization for regenerated skin under the SUPERB brand; and non-invasive muscle toning technology under the Pure Impact VIP brand. It serves plastic surgeons, dermatologists, and other physicians who perform aesthetic treatments on patients. It also provides technical and clinical product support services. The company was incorporated in 2015 and is based in Yokneam Illit, Israel.

Source: official company profile (Yahoo Finance), summary. Website: sofwave.com

Sources

No dividend paid over the past five years (source: Yahoo Finance).

Information, no recommendation. This site presents figures published by companies and calculations based on those figures. It is not investment advice, nor a recommendation to buy or sell, nor a valuation of the companies. Always check the original reports.